The Furlong hydroxyapatite-coated femoral prosthesis. A 4- to 7-year follow-up study

Arch Orthop Trauma Surg. 1998;117(3):132-5. doi: 10.1007/s004020050212.

Abstract

We report the clinical and radiograph outcome of 77 Furlong hydroxyapatite fully coated femoral prosthesis in 71 patients undergoing primary total hip replacement, with mean follow-up of 65 months (range 48-82 months). The patients' average age at surgery was 55 years. The clinical results, as determined by Harris hip score, were excellent or good for 84% of the hips. Thigh pain which was not disturbing was present in 9% of the hips. No femoral component had been revised for aseptic loosening, and none were considered loose radiographically at the time of final follow-up evaluation. Serial radiographs revealed an excellent quality of bone around the prostheses, with positive evidence of bone ingrowth and no signs of impending failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Arthroplasty, Replacement, Hip / methods*
  • Biocompatible Materials*
  • Chi-Square Distribution
  • Durapatite*
  • Evaluation Studies as Topic
  • Female
  • Femur*
  • Follow-Up Studies
  • Hip Joint / diagnostic imaging
  • Hip Joint / surgery
  • Hip Prosthesis* / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Pain / etiology
  • Prognosis
  • Prosthesis Design
  • Prosthesis Failure
  • Radiography
  • Reoperation
  • Surface Properties
  • Treatment Outcome

Substances

  • Biocompatible Materials
  • Durapatite